Perrigo OTC Birth Control Cleared Amid Reproductive Battle (1)

July 13, 2023, 7:08 PM UTC

Perrigo Co.’s Opill received US clearance as the first daily oral birth-control product available without a prescription, coming at a time when reproductive rights are increasingly under fire.

The decision released Thursday by the US Food and Drug Administration widens access to the drug by removing barriers to obtaining oral contraception, such as inability to get a doctor’s appointment.

Birth control and reproductive health have risen to the top of the legislative and political agenda since the Supreme Court overturned the Roe v. Wade ruling that guaranteed a constitutional right to abortion for about 50 years. President Joe Biden ...



Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.